Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Neurol Neurosurg ; 113(4): 277-80, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21159421

RESUMO

OBJECTIVES: To report the results from the Brazilian database on multiple sclerosis (MS) and pregnancy. METHODS: Retrospective data from MS patients who became pregnant at any time of their disease were sent to a Brazilian database, using a specific file for this purpose. RESULTS: Data on 128 women (142 pregnancies) from 30 neurologists working in 21 cities in Brazil were collected. Patients' average age at pregnancy was 29.8 years (range 16-42). EDSS at start of pregnancy was 1.5±1.4; and the relapse rate in the year preceding pregnancy was 1.2±1.5. Exposure to medication at any time during pregnancy was high (69.7%): 48.6% to interferon beta; 14.1% to glatiramer acetate; and 7% to other immunomodulatory and immunosuppressive drugs. There was a significant decrease in relapse rate during pregnancy. The prevalence of complications was relatively low, with 4.9% of obstetric and 1.4% neonatal unfavorable outcomes. CONCLUSIONS: Our patients had low degrees of disability, short histories of disease, high drug exposure, and relatively high relapse rate in the year previous to pregnancy. Obstetric and neonatal outcomes were successful in over 90% of our patients.


Assuntos
Esclerose Múltipla/epidemiologia , Complicações na Gravidez/epidemiologia , Adolescente , Adulto , Peso ao Nascer/efeitos dos fármacos , Brasil/epidemiologia , Interpretação Estatística de Dados , Bases de Dados Factuais , Feminino , Acetato de Glatiramer , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Recém-Nascido , Doenças do Recém-Nascido/epidemiologia , Interferon Tipo I/efeitos adversos , Interferon Tipo I/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Peptídeos/efeitos adversos , Peptídeos/uso terapêutico , Gravidez , Resultado da Gravidez , Proteínas Recombinantes , Recidiva , Estudos Retrospectivos , Adulto Jovem
2.
Acta Paediatr ; 94(4): 501-4, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16092468

RESUMO

UNLABELLED: Orofacial granulomatosis is a term generally used to describe lip swelling secondary to an underlying granulomatous inflammatory process. Granulomatous cheilitis is the histopathological description of such inflammation occurring in the lips and surrounding tissues. Melkersson-Rosenthal syndrome (a triad of orofacial swelling, facial paralysis and a fissured tongue) is one manifestation of orofacial granulomatosis, which more commonly presents as granulomatous cheilitis alone. Oral Crohn's disease also belongs to the entity of orofacial granulomatosis. Most reported cases of orofacial granulomatosis have been in adults and some in adolescents. We present six children presenting with orofacial granulomatosis at an early age (range 5-8 y) whose course points towards the development of Crohn's disease. CONCLUSION: Orofacial granulomatosis in the paediatric population may be an initial manifestation of Crohn's disease and so careful surveillance is recommended.


Assuntos
Doença de Crohn/complicações , Síndrome de Melkersson-Rosenthal/etiologia , Criança , Feminino , Humanos , Masculino , Síndrome de Melkersson-Rosenthal/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA